ドイツは、医薬品の適切な使用の不可欠な部分として、支払者、医療提供者、患者にバイオシミラーの受け入れを達成しました。バイオシミラーへの患者の即時アクセスを含め、会社が設定した価格から全額が償還されます。複数の購買グループと個別の病院チェーンによる病院入札の構造により、ドイツではメーカー間の競争が維持されます。たとえば、2018 年 11 月にドイツ保健省は医薬品供給の安全性に関する法案を提出しました。 Gesetz für Mehr Sicherheit in der Arzneimittelversor-gung (GSAV) 法案は、ドイツの薬剤師によるバイオシミラーの自動代替のための法的枠組みを提供することを目的としています。
国際糖尿病連盟、欧州医薬品庁、疾病管理予防センター、中国臨床腫瘍学、National Comprehensive Care Network は、ヨーロッパのバイオシミラー市場に関するレポートを作成する際に参照される主要な一次および二次情報源の一部です。
Europe Biosimilars Strategic Insights
Strategic insights for Europe Biosimilars involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
The regional scope of Europe Biosimilars refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
Get more information on this report
Identical Market Reports with other Region/Countries
The Europe Biosimilars Market is valued at US$ 10,344.86 Million in 2022, it is projected to reach US$ 1,15,125.91 Million by 2030.
What is the CAGR for Europe Biosimilars Market by (2022 - 2030)?
As per our report Europe Biosimilars Market, the market size is valued at US$ 10,344.86 Million in 2022, projecting it to reach US$ 1,15,125.91 Million by 2030. This translates to a CAGR of approximately 35.1% during the forecast period.
What segments are covered in this report?
The Europe Biosimilars Market report typically cover these key segments-
疾患適応症 (がん, 糖尿病, 自己免疫疾患, その他の疾患適応症)
投与経路 (静脈内, 皮下)
薬物クラス (顆粒球コロニー刺激因子, インスリン, TNF阻害剤, モノクローナル抗体)
What is the historic period, base year, and forecast period taken for Europe Biosimilars Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Biosimilars Market report:
Historic Period : 2020-2021
Base Year : 2022
Forecast Period : 2023-2030
Who are the major players in Europe Biosimilars Market?
The Europe Biosimilars Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Amgen Inc
Celltrion Inc
Sanofi SA
Biocon Ltd,
Samsung Bioepis Co Ltd
Elli Lilly and Co
Sandoz AG
Teva Pharmaceitical Industries Ltd
Pfizer Inc
Dr. Reddys Laboratories Ltd
Who should buy this report?
The Europe Biosimilars Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the Europe Biosimilars Market value chain can benefit from the information contained in a comprehensive market report.
Personal & transactional information is kept safe from unauthorized use.
WHAT'S INCLUDED IN FULL REPORT : Market Dynamics,
Competitive Analysis and Assessment, Define Business Strategies, Market Outlook and
Trends, Market Size and Share Analysis, Growth Driving Factors, Future Commercial
Potential, Identify Regional Growth Engines